Abstract:Introduction. Until the 1990s, there was no available treatment for chronic
hepatitis C, but during this decade the benefits of interferon-alfa therapy
were reported. At the end of the 1990s, the pegylated interferon-alfa 2a/b
has significantly altered the treatment, whereas direct acting antivirals
have significantly affected the treatment. The aim of this study was to show
the most significant predictive factors of therapy response among patients
with chronic hepatitis C treated with pegyla… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.